REPARE THERAPEUTICS INC (RPTX) Stock Income Statement
NASDAQ:RPTX - Nasdaq - US7602731025 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.07M | 53.48M | 51.13M | 131.80M | 7.60M | |||
| Operating Expenses | 131.56M | 145.62M | 167.36M | 151.60M | 116.30M | |||
| Research and Development | 103.24M | 115.94M | 131.76M | 117.20M | 88.70M | |||
| Selling, General, and Administrative Expenses | 28.72M | 29.68M | 33.65M | 32.40M | 26.10M | |||
| Operating Income | -130.56M | -92.14M | -116.22M | -19.80M | -108.70M | |||
| Interest Income/Expense | 8.93M | 10.39M | 13.16M | 5.90M | 100.00K | |||
| Other Income/Expense | -114.00K | -115.00K | -119.00K | 0.00 | 0.00 | |||
| Non Recurring Items | N/A | -1.38M | N/A | N/A | N/A | |||
| Income Before Taxes | -126.27M | -83.25M | -103.18M | -13.90M | -108.60M | |||
| Income Tax | 1.19M | 1.44M | -9.38M | 15.10M | -1.70M | |||
| Net Income | -128.12M | -84.69M | -93.80M | -29.00M | -106.90M | |||
| EBITDA | -127.96M | -90.22M | -114.27M | -17.82M | -107.23M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.01 | -2.00 | -2.23 | -0.69 | -2.83 | |||
| Non GAAP EPS | -2.93 | -2.00 | -2.23 | -0.78 | -2.82 | |||
| Statistics | ||||||||
| Profit Margin | -11940.35% | -158.37% | -183.44% | -22.00% | -1406.58% | |||
| Operating Profit Margin | -12168.03% | -172.31% | -227.30% | -15.02% | -1430.26% | |||
All data in USD